Search

everythinglearnresearchcommunity

for

Search:↓

A 63-year-old woman's male-like symptoms were caused by a rare testosterone-producing ovarian tumor, treated by removing her ovaries and fallopian tubes.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

Prostatitis is a common male condition with various causes and treatments, often involving antibiotics and lifestyle changes.

Radiation cystitis patients need better monitoring and early treatment due to higher readmission rates.

Combination therapy for 9+ months maintains symptom improvements after stopping alpha-blockers or finasteride.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Choosing the right recall period for patient feedback is important for accurate data and depends on the disease, symptom changes, and patient impact.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Berberine may reduce prostate enlargement by blocking inflammation.

Method accurately measures finasteride and tamsulosin in combined drug form.

Two methods can measure finasteride and tamsulosin hydrochloride; HPLC is more advantageous, while TLC offers better separation.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Created method to measure doxazosin mesylate and finasteride together.

Antihelminthic drugs treat worm infections but face challenges like low treatment coverage and potential drug resistance, with various side effects reported for different drugs.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

Finasteride lowers PSA levels and prostate size, requiring adjusted PSA interpretation for accurate cancer screening.

Olive leaves extract may help treat benign prostatic hyperplasia (BPH).

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Surgery for high-risk prostate cancer is challenging but doesn't lead to more complications, and additional treatment is often needed.

Cone beam computed tomography can allow for smaller safety margins around the target area in prostate cancer radiation treatment if used for ongoing treatment checks.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Combining D-004 and finasteride is more effective at reducing prostate enlargement than using either alone.

Finasteride effectively treats hematospermia in 3 months without side effects.

Finasteride interacts with terazosin, but not doxazosin; caution needed.